Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

Can Pharm J (Ott). 2019 Jan 24;152(2):92-108. doi: 10.1177/1715163518811065. eCollection 2019 Mar-Apr. Review.

2.

The evolution of pharmacy practice research-Part I: Time to implement the evidence.

Tsuyuki RT, Bond C.

Can Pharm J (Ott). 2019 Feb 17;152(2):71-72. doi: 10.1177/1715163519828318. eCollection 2019 Mar-Apr. No abstract available.

3.

Reply from the authors.

Tsuyuki RT, Okada H, Houle SKD.

Can Pharm J (Ott). 2018 Dec 17;152(1):9. doi: 10.1177/1715163518816044. eCollection 2019 Jan-Feb. No abstract available.

4.

A leadership crisis in pharmacy.

Tsuyuki RT.

Can Pharm J (Ott). 2018 Dec 12;152(1):6-7. doi: 10.1177/1715163518816963. eCollection 2019 Jan-Feb. No abstract available.

5.

Evidence and its impact on pharmacy practice: Don't be "evidence-illiterate".

Sanyal C, Husereau D, Tsuyuki RT.

Can Pharm J (Ott). 2018 Oct 11;151(6):357-358. doi: 10.1177/1715163518805404. eCollection 2018 Nov-Dec. No abstract available.

6.

Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial.

Turgeon RD, Tsuyuki RT, Gyenes GT, Pearson GJ.

Can J Cardiol. 2018 Dec;34(12):1600-1605. doi: 10.1016/j.cjca.2018.04.002.

PMID:
30527147
7.

Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the RxEACH study.

Al Harmarneh YN, Lamb S, Donald M, Hemmelgarn B, King Shier K, Jones CA, Mitchell C, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 30;151(4):223-227. doi: 10.1177/1715163518779092. eCollection 2018 Jul-Aug. No abstract available.

8.

FAQs (frequent asinine questions) on pharmacists' scope of practice.

Tsuyuki RT.

Can Pharm J (Ott). 2018 Jun 4;151(4):212-213. doi: 10.1177/1715163518779790. eCollection 2018 Jul-Aug. No abstract available.

9.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):89-107. doi: 10.1016/j.japh.2018.07.002. Epub 2018 Sep 6.

PMID:
30195440
10.

Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen.

Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, Krass I, Obarcanin E, Saevels J, Srimongkon P, Teichert M, Tsuyuki RT.

Int J Clin Pharmacol Ther. 2018 Nov;56(11):518-530. doi: 10.5414/CP203264.

PMID:
30106363
11.

Reply from authors.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 4;151(3):158. doi: 10.1177/1715163518767828. eCollection 2018 May-Jun. No abstract available.

12.

Pharmacists as cognitive authorities: Why this is important in advancing patient care and our profession.

Tsuyuki RT, Hirsh J.

Can Pharm J (Ott). 2018 May 4;151(3):155-156. doi: 10.1177/1715163518767827. eCollection 2018 May-Jun. No abstract available.

13.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
14.

Hot joints: myth or reality? A thermographic joint assessment of inflammatory arthritis patients.

Jones B, Hassan I, Tsuyuki RT, Dos Santos MF, Russell AS, Yacyshyn E.

Clin Rheumatol. 2018 Sep;37(9):2567-2571. doi: 10.1007/s10067-018-4108-0. Epub 2018 Apr 20.

PMID:
29679167
15.

Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Nov 29;151(1):33-42. doi: 10.1177/1715163517743525. eCollection 2018 Jan-Feb. No abstract available.

16.

Pharmacists as accessible primary health care providers: Review of the evidence.

Tsuyuki RT, Beahm NP, Okada H, Al Hamarneh YN.

Can Pharm J (Ott). 2018 Jan 2;151(1):4-5. doi: 10.1177/1715163517745517. eCollection 2018 Jan-Feb. No abstract available.

17.

Effects of lifestyle advice provided by pharmacists on blood pressure: The COMmunity Pharmacists ASSist for Blood Pressure (COMPASS-BP) randomized trial.

Okada H, Onda M, Shoji M, Sakane N, Nakagawa Y, Sozu T, Kitajima Y, Tsuyuki RT, Nakayama T.

Biosci Trends. 2018 Jan 9;11(6):632-639. doi: 10.5582/bst.2017.01256. Epub 2017 Dec 18.

18.

Active versus passive adverse event reporting after pediatric chiropractic manual therapy: study protocol for a cluster randomized controlled trial.

Pohlman KA, Carroll L, Tsuyuki RT, Hartling L, Vohra S.

Trials. 2017 Dec 1;18(1):575. doi: 10.1186/s13063-017-2301-0.

19.

Innovative pharmacy practice: Lonni Johnson.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Jul 7;150(4):233-235. doi: 10.1177/1715163517713486. eCollection 2017 Jul-Aug. No abstract available.

20.

Authors' response.

Bachynsky JA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Jul 7;150(4):228. doi: 10.1177/1715163517715013. eCollection 2017 Jul-Aug. No abstract available.

21.

The ultimate opportunity for advancing pharmacy practice.

Tsuyuki RT, Berg A, Khan NA.

Can Pharm J (Ott). 2017 Jun 1;150(4):225-226. doi: 10.1177/1715163517712938. eCollection 2017 Jul-Aug. No abstract available.

22.

Innovative pharmacy practice: Cathy Biggs.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Oct 5;150(6):359-361. doi: 10.1177/1715163517735310. eCollection 2017 Nov-Dec. No abstract available.

23.

Measuring the impact of CPJ on pharmacy practice.

Chatterley T, Tsuyuki RT.

Can Pharm J (Ott). 2017 Oct 24;150(6):347-348. doi: 10.1177/1715163517734838. eCollection 2017 Nov-Dec. No abstract available.

24.

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT.

Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244. Epub 2017 Sep 28.

PMID:
28965748
25.

Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial.

Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N, Jindal K, Tink W, Hemmelgarn BR.

Am J Kidney Dis. 2018 Jan;71(1):42-51. doi: 10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12.

PMID:
28912054
26.

The assessment and management of urinary tract infections in adults: Guidelines for pharmacists.

Beahm NP, Nicolle LE, Bursey A, Smyth DJ, Tsuyuki RT.

Can Pharm J (Ott). 2017 Jul 31;150(5):298-305. doi: 10.1177/1715163517723036. eCollection 2017 Sep-Oct. No abstract available.

27.

Guidelines for the management of atopic dermatitis (eczema) for pharmacists.

Wong ITY, Tsuyuki RT, Cresswell-Melville A, Doiron P, Drucker AM.

Can Pharm J (Ott). 2017 May 30;150(5):285-297. doi: 10.1177/1715163517710958. eCollection 2017 Sep-Oct. No abstract available.

28.

Predatory publishers: Implications for pharmacy practice and practitioners.

Tsuyuki RT, Al Hamarneh YN, Bermingham M, Duong E, Okada H, Beall J.

Can Pharm J (Ott). 2017 Sep 1;150(5):274-275. doi: 10.1177/1715163517725269. eCollection 2017 Sep-Oct. No abstract available.

29.
30.

Insights Into the Current Management of Older Adults With Type 2 Diabetes in the Ontario Primary Care Setting.

Meneilly GS, Berard LD, Cheng AYY, Lin PJ, MacCallum L, Tsuyuki RT, Yale JF, Nasseri N, Richard JF, Goldin L, Langer A, Tan MK, Leiter LA.

Can J Diabetes. 2018 Feb;42(1):23-30. doi: 10.1016/j.jcjd.2017.03.003. Epub 2017 Jun 2.

PMID:
28583470
31.

Cost-effectiveness of pharmacist care for managing hypertension in Canada.

Marra C, Johnston K, Santschi V, Tsuyuki RT.

Can Pharm J (Ott). 2017 Mar 21;150(3):184-197. doi: 10.1177/1715163517701109. eCollection 2017 May-Jun.

32.

Innovative pharmacy practice: Rick Siemens.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Apr 6;150(3):143-145. doi: 10.1177/1715163517702354. eCollection 2017 May-Jun. No abstract available.

33.

Les pharmaciens par rapport aux employeurs : Une épreuve de force entre l’autonomie professionnelle et les soins aux patients?

Lamb S, Tsuyuki RT.

Can Pharm J (Ott). 2017 Apr 9;150(3):140-141. doi: 10.1177/1715163517703370. eCollection 2017 May-Jun. French. No abstract available.

PMID:
28507646
Free PMC Article
34.

Pharmacists vs employers: A showdown over professional autonomy and patient care?

Lamb S, Tsuyuki RT.

Can Pharm J (Ott). 2017 Apr 7;150(3):138-139. doi: 10.1177/1715163517702352. eCollection 2017 May-Jun. No abstract available.

35.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
36.

Innovative pharmacy practice: Chloe McMillan.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2017 Feb 8;150(2):78-80. doi: 10.1177/1715163517691037. eCollection 2017 Mar-Apr. No abstract available.

37.

Information trompeuse sur le coût élevé des médicaments: Qui se préoccupe des patients?

Bachynsky JA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Mar 1;150(2):76-77. doi: 10.1177/1715163517692562. eCollection 2017 Mar-Apr. French. No abstract available.

PMID:
28405248
Free PMC Article
38.

The misrepresentation of high drug costs: Who is looking out for the patient?

Bachynsky JA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Mar 1;150(2):74-75. doi: 10.1177/1715163517691254. eCollection 2017 Mar-Apr. No abstract available.

39.

Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study.

Donald M, King-Shier K, Tsuyuki RT, Al Hamarneh YN, Jones CA, Manns B, Tonelli M, Tink W, Scott-Douglas N, Hemmelgarn BR.

CMAJ Open. 2017 Mar 6;5(1):E205-E212. doi: 10.9778/cmajo.20160135. eCollection 2017 Jan-Mar.

40.

Innovative pharmacy practice: Melanie Danilak.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2016 Dec 8;150(1):14-16. doi: 10.1177/1715163516681998. eCollection 2017 Jan-Feb. No abstract available.

41.

Taking practice innovation to the next level.

Beahm NP, Tsuyuki RT.

Can Pharm J (Ott). 2016 Dec 6;150(1):9. doi: 10.1177/1715163516681996. eCollection 2017 Jan-Feb. No abstract available.

42.

Overcoming our nature and nurture.

Rosenthal MM, Austin Z, Farrell J, Tsuyuki RT.

Can Pharm J (Ott). 2016 Dec 6;150(1):5-7. doi: 10.1177/1715163516682438. eCollection 2017 Jan-Feb. No abstract available.

43.

Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.

McMahon KR, Rod Rassekh S, Schultz KR, Pinsk M, Blydt-Hansen T, Mammen C, Tsuyuki RT, Devarajan P, Cuvelier GD, Mitchell LG, Baruchel S, Palijan A, Carleton BC, Ross CJ, Zappitelli M; Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Group.

Can J Kidney Health Dis. 2017 Feb 16;4:2054358117690338. doi: 10.1177/2054358117690338. eCollection 2017.

44.

Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Houle SK, Charrois TL, McAlister FA, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):345-351. Epub 2016 Oct 3.

45.

Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update.

Al Hamarneh YN, Houle SK, Padwal R, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):337-344. Epub 2016 Oct 6. No abstract available.

46.

Barriers to pharmacy practice change: Is it our nature or nurture?

Rosenthal MM, Austin Z, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):317-319. Epub 2016 Oct 6. No abstract available.

47.

What Are Effective Program Characteristics of Self-Management Interventions in Patients With Heart Failure? An Individual Patient Data Meta-analysis.

Jonkman NH, Westland H, Groenwold RH, Ågren S, Anguita M, Blue L, Bruggink-André de la Porte PW, DeWalt DA, Hebert PL, Heisler M, Jaarsma T, Kempen GI, Leventhal ME, Lok DJ, Mårtensson J, Muñiz J, Otsu H, Peters-Klimm F, Rich MW, Riegel B, Strömberg A, Tsuyuki RT, Trappenburg JC, Schuurmans MJ, Hoes AW.

J Card Fail. 2016 Nov;22(11):861-871. doi: 10.1016/j.cardfail.2016.06.422. Epub 2016 Jun 30. Review.

48.

The Effect of Nurse Practitioner-Led Intervention in Diabetes Care for Patients Admitted to Cardiology Services.

Li S, Roschkov S, Alkhodair A, O'Neill BJ, Chik CL, Tsuyuki RT, Gyenes GT.

Can J Diabetes. 2017 Feb;41(1):10-16. doi: 10.1016/j.jcjd.2016.06.008. Epub 2016 Sep 19.

PMID:
27658765
49.
50.

Pharmacy practice research produces findings that inform how pharmacists contribute to optimal drug therapy outcomes for Canadians.

Dolovich L, Tsuyuki RT.

Can Pharm J (Ott). 2016 Sep;149(5):261-263. Epub 2016 Aug 8. No abstract available.

Supplemental Content

Loading ...
Support Center